Abstract
Oxidative stress and hypoxia in the retinal pigment epithelium (RPE) have long been considered major risk factors in the pathophysiology of age-related macular degeneration (AMD), but systematic investigation of the interplay between these two risk factors was lacking. For this purpose, we treated a human RPE cell line (ARPE-19) with sodium iodate (SI), an oxidative stress agent, together with dimethyloxalylglycine (DMOG) which leads to stabilization of hypoxia-inducible factors (HIFs), key regulators of cellular adaptation to hypoxic conditions. We found that HIF stabilization aggravated oxidative stress-induced cell death by SI and iron-dependent ferroptosis was identified as the main cell death mechanism. Ferroptotic cell death depends on the Fenton reaction where H2O2 and iron react to generate hydroxyl radicals which trigger lipid peroxidation. Our findings clearly provide evidence for superoxide dismutase (SOD) driven H2O2 production fostering the Fenton reaction as indicated by triggered SOD activity upon DMOG + SI treatment as well as by reduced cell death levels upon SOD2 knockdown. In addition, iron transporters involved in non-transferrin-bound Fe2+ import as well as intracellular iron levels were also upregulated. Consequently, chelation of Fe2+ by 2’2-Bipyridyl completely rescued cells. Taken together, we show for the first time that HIF stabilization under oxidative stress conditions aggravates ferroptotic cell death in RPE cells. Thus, our study provides a novel link between hypoxia, oxidative stress and iron metabolism in AMD pathophysiology. Since iron accumulation and altered iron metabolism are characteristic features of AMD retinas and RPE cells, our cell culture model is suitable for high-throughput screening of new treatment approaches against AMD.
Similar content being viewed by others
Introduction
Age-related macular degeneration (AMD) is the most common blinding disease in elderly people in developed countries and represents the third leading cause for blinding worldwide [1, 2]. AMD patients develop distorted central vision which can progress to loss of central, high acuity vision caused by a gradual degeneration of photoreceptors in the macula. AMD is a complex disease with not yet fully understood pathophysiology comprising several risk factors from which oxidative stress and decreased oxygen supply, i.e. hypoxia, are considered most severe [3,4,5]. In the aging retina, protective mechanisms such as superoxide dismutases (SODs), glutathione peroxidases (GPXs) or catalase become less effective resulting in accumulation of oxidative damage [5,6,7]. Hypoxia is caused by age-related structural changes of the blood retinal barrier, leading to deteriorated supply of photoreceptors with nutrients and oxygen through retinal pigment epithelium (RPE) cells, a monolayer of pigmented cells located between the photoreceptors and the choriocapillaris. Most AMD patients (~90%) develop dry AMD or geographic atrophy which is associated with dysfunction and gradual degeneration of RPE cells, choriocapillaris, and photoreceptors. The other late form is wet or neovascular AMD, which is associated with choroidal neovascularization, vessel leakage and scarring of the retina [1, 5, 8]. Unfortunately, there is still no convincing treatment for dry AMD [9]. To develop new treatment strategies for dry AMD, it is necessary to gain deeper insights into the pathophysiological pathways leading to RPE degeneration on the molecular level. Reducing RPE damage before the transition of early AMD to late AMD could be key to prevent dry AMD, because photoreceptor degeneration in dry AMD is caused by dysfunctional RPE cells that get atrophic [7, 9, 10]. Apoptosis, necroptosis, and ferroptosis are considered to be involved in RPE atrophy and AMD pathophysiology [11,12,13]. Apoptosis is the classic mode of regulated cell death involving several modulators and pathways in which caspases play a crucial role. Necroptosis is regulated by successive activation of receptor interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain like pseudokinase (MLKL) resulting in cell permeabilization and cell membrane rupture. Ferroptosis is a cell death mode associated with lipid peroxidation of polyunsaturated fatty acids leading to plasma membrane rupture. Lipid peroxidation is caused by hydroxyl radicals which are produced in the Fenton reaction where intracellular labile iron and H2O2 serve as substrates [11, 14, 15].
Many studies have already investigated modes of RPE cell death by inducing oxidative stress to RPE cells [16,17,18,19,20]. However, the histopathology of dry AMD suggests that oxidative stress is accompanied by hypoxia [7]. Hypoxia triggers the stabilization of hypoxia-inducible factors (HIFs), cellular oxygen sensors facilitating the adaptation to hypoxic conditions by regulating a majority of oxygen-dependent genes. HIFs are dimeric transcription factors with an oxygen-labile α-subunit and a constitutively expressed β-subunit located in the nucleus [21, 22]. Under normoxic conditions, prolyl hydroxylases named PHD1, PHD2, and PHD3 hydroxylate the α-subunit by which they are marked for proteasomal degradation. PHD activity is strictly dependent on oxygen, thus under hypoxic conditions hydroxylation stops, HIF-α subunits are stabilized, translocate to the nucleus, dimerize with the β-subunit and initiate expression of hypoxia-responsive genes [23]. To date three HIF isoforms are known from which HIF-1 and HIF-2 are considered most relevant for the hypoxia response [24]. HIFs are protective factors in the short-term but chronic hypoxia like it is observed in AMD can be detrimental due to HIF-dependent inflammation, neovascularization, metabolic shift or impaired lipid transport [3, 25,26,27]. Consequently, an in vitro RPE model combining oxidative stress and hypoxia would resemble the situation observed in dry AMD. To our knowledge, no such model is available thus far, limiting the knowledge on molecular pathways involved in dry AMD pathophysiology. In the present study, we used a human RPE cell line, ARPE-19, and induced oxidative stress as well as HIF stabilization in order to investigate the interplay of these two risk factors in RPE degeneration.
Material and methods
Reagents and Antibodies
The following non-standard reagents were used in the study: Sodium iodate (SI; sc-251029, Santa Cruz Biotechnology, Heidelberg, Germany), dimethyloxalylglycine (DMOG; Cay-71210, Cayman Chemical, Ann Arbor, MI), diethyldithiocarbamate (228680, Sigma Aldrich, Taufkirchen, Germany), phenylmethylsulfonyl fluoride (10837091001, Sigma Aldrich), Z-VAD-FMK (ab120487, Abcam, Cambridge, UK), Nec-1s (ab221984, Abcam), GSK872 (ab254395, Abcam), Necrosulfonamide (NSA) (480073, Sigma Aldrich), Ferrostatin-1 (Fer-1; ab146169, Abcam), Liproxstatin-1 (Lip-1; Cay-17730, Cayman Chemical), Deferoxamine Mesylate (ab120727, Abcam), 2’2-Bipyridyl (D216305-2, Sigma Aldrich), and DharmaFECT 4 Transfection Reagent (T-2004-02, Horizon Discovery, Waterbeach, UK). The following antibodies were used: Anti-HIF-1α (610958, BD Biosciences, Franklin Lakes, NJ), anti-HIF-2α (NB100-122, Novus Biologicals, Littleton, CO), anti-SOD2 (13141 S, Cell Signaling Technology, Danvers, MA, USA), anti-GPX1 (3206 S, Cell Signaling Technology), anti-ZIP8 (20459-1-AP, Proteintech Germany GmbH, Planegg-Martinsried, Germany), anti-DMT1 (20507-1-AP, Proteintech), anti-TFR1 (66180-1-IG, Proteintech), anti-GPX4 (ab125066, Abcam), anti-Tubulin (sc-8035, Santa Cruz), anti-ZIP14 (PA5-21077, Thermo Fisher Scientific, Waltham, MA), anti-FTH (sc-376594, Santa Cruz Biotechnology), anti-FTL (68068-1-Ig, Proteintech), anti-Actin (A2103, Sigma Aldrich), as well as goat anti-mouse (A2304, Sigma Aldrich), and goat anti-rabbit (A0545, Sigma Aldrich) secondary antibodies.
Cell culture
Human RPE cells (ARPE-19, CRL-2302, American Type Culture Collection, Manassas, VA; distributed by LGC Standards GmbH, Wesel, Germany) were routinely cultured in a mixture of Dulbecco’s modified Eagle’s medium (DMEM)/F-12 with GlutaMAX (31331028, Thermo Fisher Scientific), supplemented with 10% fetal bovine serum and penicillin–streptomycin (full growth medium) at 37 °C under 21% O2 and 5% CO2. All experiments were conducted with DMEM/F12 supplemented with 1% FBS under 3% O2 (23 mmHg) in a hypoxia chamber to simulate physioxic conditions [28,29,30]. In order to resemble AMD pathophysiology in ARPE-19 cells, we induced oxidative stress by SI, an established oxidizing agent used to induce AMD-like phenotype in RPE cells [16, 18, 31, 32]. We further induced HIF-α stabilization by DMOG, a PHD inhibitor, which results in HIF stabilization. SI and DMOG stock solutions were prepared in DMEM/F12. Cells were authenticated by STR profiling and routinely tested for mycoplasma contamination. All experiments were conducted within five passages.
LDH assay
To assess cell viability, LDH release was measured using a CyQUANT™ LDH Cytotoxicity Assay (C20301, Thermo Fisher Scientific). Briefly, cells were seeded at a density of 10,000 cells/well in a 96-wellplate. Confluent cells were treated for 24 h under 3% O2. Subsequently, 50 µL of cell culture medium was transferred to a 96-wellplate and subjected to LDH measurement according to manufacturer’s instructions. Absorbance was measured at 490 nm with a plate reader.
Annexin V apoptosis detection assay
A PE Annexin V Apoptosis Detection Kit (559763, BD Biosciences) was used to determine the number of dead cells upon treatment with DMOG and/or SI. ARPE-19 cells were seeded in 6-wellplates at a density of 200,000 cells/well. Confluent cells were treated with SI and/or DMOG for 20 h hours. After treatment, medium was collected and centrifuged at 500 rcf for 5 min to collect already detached cells. Adherent cells were collected by trypsinization and centrifuged at 500 rcf for 5 min. Cells were subsequently washed with PBS twice and resuspended in 100 µL Annexin V binding buffer. The cell suspension was incubated for 15 min with 5 µL Annexin V conjugated to phycoerythrin (PE) and 5 µL 7-Aminoactinomycin (7-AAD). All samples were analyzed with a FACSCelesta TM Flow Cytometer (BD Biosciences).
siRNA transfection
For siRNA knockdown of SOD2, ARPE-19 cells were transfected with 50 nM ON-TARGETplus Human SOD2 siRNA (L-009784-00-0005, Horizon Discovery) or scrambled control siRNA (D-001810-10-05, Horizon Discovery). In brief, at approximately 70% confluency, cells were transfected with siRNA in a mixture of DharmaFECT 4 (final dilution in well: 1:400) and OptiMEM (31985062, Thermo Fisher Scientific) diluted in DMEM/F12 supplemented with 10% FBS without the addition of antibiotics. After 6 h incubation, medium was changed to full growth medium and cells were cultured for another 48 hours before conducting experiments.
Western blot
Cells were washed with cold PBS and collected in lysis buffer in a hypoxia chamber, incubated on ice for 20 min and centrifuged for 5 min at 500 rpm. The supernatant was collected and stored at −80 °C until use. 30 µg of total protein were incubated in Laemmli sample buffer for 5 min at 95 °C and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Separated proteins were transferred to a PVDF membrane using a Trans-Blot Turbo Transfer System (Bio-Rad Laboratories, Feldkirchen, Germany). Membranes were blocked with 5% non-fat dry milk in TBS-T for 1 h at room temperature. Primary antibodies were diluted in blocking buffer and incubated overnight at 4 °C. Secondary antibodies were diluted in blocking buffer (1:10,000) and incubated 1 h at room temperature. Signals were developed with SuperSignal West Femto Maximum Sensitivity Substrate (34096, Thermo Fisher Scientific) and detected with a Fusion FX System (Vilber, Eberhardzell, Germany).
Quantitative Real-Time PCR
Total RNA was isolated using the NucleoSpin RNA kit (740955.250, MACHEREY-NAGEL, Düren Germany) according to the manufacturer’s instructions. Complementary DNA (cDNA) was synthesized from 500 ng total RNA using M-MLV reverse transcriptase (M1705, Promega, Walldorf, Germany) and oligo dT primer. Quantitative Real-Time PCR (qRT-PCR) was performed with a Biozym Blue S’Green master mix (331416XL, Biozym Scientific, Hessisch Oldendorf, Germany) on a BioRad IQ5 Real-Time PCR Detection System. Relative expression levels were calculated with the ∆∆ct method [33] using hypoxanthine-guanine phosphoribosyltransferase (HPRT) as reference gene. The following primer pairs were used: GPX1 5′-AGTCGGTGTATGCCTTCTCG-3′ forward and 5′- TCTTGGCGTTCTCCTGATGC-3′ reverse; GPX4 5′-GTGGAAGTGGATGAAGAT-3′ forward and 5′-GATGAGGAACTTGGTGAA-3′ reverse; SOD1 5′-AGGCATGTTGGAGACTTGGG-3′ forward and 5′-TGCTTTTTCATGGACCACCAG-3′ reverse; SOD2 5′-CGTTGGCCAAGGGAGATGTT-3′ forward and 5′-CACGTTTGATGGCTTCCAGC-3′ reverse; DMT1 5′-CTTTGCCAATGGACTAGGCT-3′ forward and 5′-CTTCTGTCAGCAGGCCTTTAG-3′ reverse; TFR1 5′-ACTTCTTCCGTGCTACTTCCAG-3′ forward and 5′-ACTCCACTCTCATGACACGATC-3′ reverse; ZIP8 5′-ATGCTACCCAAATAACCAGC-3′ forward and 5′-CAGGAATCCATATCCCCAAAC-3′ reverse; ZIP14 5′-TAAGCAGAAAAATGAGCATC-3′ forward and 5′-ACCTTTCAGCCAGTAGCAAG-3′ reverse; HPRT 5′-CCTGGCGTCGTGATTAGTGA-3′ forward and 5′-CGAGCAAGACGTTCAGTCCT-3′ reverse.
Superoxide dismutase activity assay
Superoxide dismutase (SOD) activity in ARPE-19 cells was measured using a colorimetric assay (19160, Sigma Aldrich). Measurements were conducted according to manufacturer’s instructions. Briefly, cells were seeded in 6-wellplates at a density of 200,000 cells per well. Upon confluence, cells were treated with SI and/or DMOG for 16 h at 3% O2. After treatment, cells were lysed using an ice-cold lysis buffer containing 0.1 mM Tris/HCl (pH 7.4), 0.5% Triton X-100, 5 mM β-Mercaptoethanol, and 0.1 mg/mL phenylmethylsulfonyl fluoride and centrifuged to collect the supernatant. One part of each sample was measured directly, and the other part was incubated with 2 mM diethyldithiocarbamate to chelate Cu to inactivate SOD1 in order to measure SOD2 activity. All samples were measured in triplicate and absorbance was read at 450 nm. SOD activities were normalized to total protein content.
Image-iT lipid peroxidation assay
Cells were seeded at 40,000 cells/well in 24-wellplates and treated with SI and/or DMOG the next day for 16 h under 3% O2 in a hypoxia chamber. After treatment, cells were washed with warm culture medium three times and incubated for 30 min under 3% O2 with 10 µM Image-iT lipid peroxidation sensor (C10445, Thermo Fisher Scientific). After incubation, cells were washed with PBS and fixed with 4% paraformaldehyde for 15 min at 3% O2. The Image-iT lipid peroxidation sensor is based on BODIPY 581/591 C11 which has a fluorescence emission peak at approximately 590 nm in its native form. Upon oxidation, the emission shifts to approximately 510 nm. Fluorescence signal was detected using an Eclipse Ts2-FL fluorescence microscope (Nikon, Amsterdam, Netherlands) and quantified with IMAGEJ.
Detection of Fe2+ and Fe3+ using flow cytometry
Cells were plated in 6-wellplates at a density of 200,000 cells/well. Confluent cells were treated with SI and/or DMOG and kept in hypoxic conditions (3% O2) for 8 h or 16 h. For Fe2+ quantification, cell pellets were stained with 10 µM Rhodamine B-[(1,10-phenanthroline-5-yl)-aminocarbonyl]benzylester (RPA, Squarix Biotechnology, Marl, Germany) for 12 min, washed with PBS and incubated in PBS for 15 min at 37 °C. For Fe3+ quantification, cell pellets were stained with 10 µM 7-Nitrobenz-2-oxa-1,3-diazole-desferrioxamine (NDB-DFO, Squarix Biotechnology, Marl, Germany) for 12 min, washed with PBS and incubated in PBS for 15 min at 37 °C. The mean fluorescence intensity (MFI) was detected by flow cytometry (BD CytoFLEX S, Beckman Coulter; FL-2). Fold changes were quantified to the corresponding non-treated controls as previously described [34]. In brief, RPA fluorescence is quenched by Fe2+ allowing the determination of iron reduction [35, 36], and NBD-DFO fluorescence is quenched by Fe3+ allowing the determination of ferric iron [37].
Statistical analyses
Statistical analyses were performed using GraphPad Prism software (Version 8.0, San Diego, CA, USA). Analyses were conducted using two-tailed unpaired t-test, one-way ANOVA with Tukey’s multiple comparisons test or two-way ANOVA with Tukey’s multiple comparisons test according to the recommendations of Lord et al. [38]. Western blot data were normalized to each control group to calculate the fold-change and log-transformed prior to analyses. All data are expressed as mean+SD. Sample sizes were chosen according to the recommendations of Naegle et al. [39] and are indicated in the respective figure legends. Statistical significance was defined as ns = p > 0.05; *p < 0.05; **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Results
HIF stabilization aggravates oxidative damage
We treated ARPE-19 cells with 0, 2.5, 5, 7.5, 10, 15 mM SI with or without DMOG in a hypoxia chamber set to 3% O2 and LDH release was determined as a measure of cell death. Cells treated with SI alone required 15 mM SI to detect significant cell death after 24 h (Fig. 1A). However, when HIFs were additionally stabilized by 1 mM DMOG, cell death was already significantly upregulated by 2.5 mM SI after 24 h while treatment with 1 mM DMOG alone had no effect on cell viability (Fig. 1A). In all SI-treated groups, co-treatment with 1 mM DMOG exacerbated cell death rate in a dose-dependent manner compared to the corresponding SI-only group. We further validated the cell death rate measured by LDH assay by two independent methods using 5 mM SI and/or 1 mM DMOG which represented concentrations that induced cell death in 43.7 ± 5.5% of cells measured by LDH release (Fig. 1B). Cell viability determined by MTT assay was decreased by 50.9 ± 10.4% in the DMOG + SI-treated cells compared to DMOG-treated cells (Fig. 1C). Annexin V assay revealed that 45.1 ± 16.8% of cells showed a necrotic phenotype when cells were treated with SI + DMOG for 20 h (Fig. 1D, E). Based on these findings, we chose a concentration of 5 mM SI and 1 mM DMOG for further viability experiments, representing a treatment regimen that yielded a reproducible cell death rate determined by three quantitative methods and microscopic observation (Fig. 1F). For mRNA and protein extraction, we reduced DMOG concentration to 0.5 mM to induce HIF stabilization (Fig. 1G, Supplementary File 1) but avoid cell death.
Ferroptosis is the main cell death pathway
In order to identify the cell death mechanism, we treated the cells with inhibitors of the apoptosis, necroptosis, and ferroptosis pathway and subjected the cells to DMOG + SI co-treatment to assess cell viability by LDH assay. Cells treated with the pan-caspase inhibitor Z-VAD-FMK, a well-established apoptosis inhibitor, displayed increased cell death when co-treated with DMOG and SI compared to controls (Fig. 2A) suggesting that apoptosis is not responsible for increased cell death; this is in line with Annexin V FACS data where almost no apoptotic cells were detected (Fig. 1D, E). The necroptosis pathway was analyzed by inhibiting RIPK1 with Nec-1s, RIPK3 with GSK872, and MLKL with NSA. Nec-1s significantly reduced cell death (Fig. 2B) and GSK872 fully rescued cells treated with DMOG + SI (Fig. 2C). However, inhibition of MLKL activation by NSA, which represents the final step in necroptosis execution, led to a statistically significant reduction of cell death, but still the majority of cells were dead, although very high concentrations of NSA were used (Fig. 2D). To test the involvement of ferroptosis, cells were treated with Fer-1 and Lip-1, which most likely inhibit ferroptosis by a radical-trapping mechanism reducing lipid peroxidation [40]. Both inhibitors were able to fully rescue cells from cell death (Fig. 2E, F), suggesting that ferroptotic cell death is the major cell death mechanism observed in our model. Ferroptosis was further confirmed with an oxidation-sensitive fluorescent lipid peroxidation probe based on C11-BODIPY581/591 which shifts its fluorescence emission from red to green upon oxidation. The green fluorescence localized mainly perinuclear which is typical for this probe in the oxidized state (Fig. 2G) and background-corrected total cell fluorescence was significantly higher in cells treated with DMOG + SI compared to controls (Fig. 2H), suggesting that cell death is induced by lipid peroxidation which is typical for ferroptosis.
SOD activity paradoxically contributed to cell death
GPXs and SODs are important antioxidant enzymes. SODs catalyze the dismutation of superoxide (O2−) into oxygen and hydrogen peroxide (H2O2). H2O2 is then broken down by GPX1 and catalase for complete detoxification. Moreover, GPX4 protects from lipid peroxidation, i.e. ferroptosis. Since SI treatment induces O2− accumulation [41], GPXs and SODs are crucial in protection against SI-induced oxidative damage. Gene expression levels of GPX1 and GPX4 were significantly downregulated in DMOG + SI co-treated cells (Fig. 3A, B). While SOD1 transcript levels were only higher in DMOG + SI co-treatment compared to SI treatment (Fig. 3C), SOD2 transcription was higher in co-treated cells compared to controls and SI treatment (Fig. 3D). In contrast to transcript levels, GPX1 and GPX4 protein levels did not differ between the treatment groups (Fig. 3E–G). On the other hand, SOD2 protein levels were significantly upregulated in DMOG + SI co-treated cells compared to controls (Fig. 3E, H). To get insights if the dismutation potential follows protein levels, we measured SOD activity with a colorimetric assay. Total SOD activity was significantly upregulated in DMOG + SI co-treatment compared to controls (Fig. 3I). SOD2 activity, measured after inactivation of SOD1 by Cu-chelation, only showed a statistical trend towards higher activity in the DMOG + SI group (Fig. 3J). These results suggest that SOD activity contributes to ferroptotic cell death induced by DMOG + SI co-treatment by producing H2O2, which is a substrate of the Fenton reaction. To test this, we conducted siRNA knockdown of SOD2 by which cell death was significantly decreased under DMOG + SI co-treatment confirming that SOD2 contributes to cell death (Fig. 3K).
Importers for non-transferrin-bound Fe2+ were upregulated in DMOG + SI co-treated cells
While gene expression of the transferrin receptor 1 (TFR1) was significantly upregulated by SI, DMOG, and DMOG + SI co-treatment (Fig. 4A), gene expression of the divalent metal transporter 1 (DMT1) was downregulated approximately 64-fold compared to controls (Fig. 4B). The two non-transferrin-bound Fe2+ importers ZIP8 and ZIP14 were expressed in a HIF-dependent but opposite manner. While DMOG and DMOG + SI co-treatment led to ZIP8 downregulation (Fig. 4C), ZIP14 was significantly upregulated in these groups (Fig. 4D). Protein levels revealed different patterns compared to transcript levels (Fig. 4E). TFR1 and DMT1 were not significantly changed by the treatments (Fig. 4F, G, Supplementary File 1), despite of a trend in TFR1 protein towards higher levels in co-treated cells (p = 0.08). In contrast, ZIP8 and ZIP14 protein levels were significantly higher when treated with DMOG + SI (Fig. 4H, I, Supplementary File 1). ZIP14 was also significantly upregulated by SI treatment. We also analyzed ferritin light chain (FTL) and ferritin heavy chain (FTH) protein, the two subunits of ferritin. FTL was significantly upregulated by SI alone and SI + DMOG co-treatment (Fig. 4J, Supplementary File 1) and FTH showed a trend towards higher levels in DMOG + SI co-treatment (Fig. 4K, Supplementary File 1).
Fe2+ but not Fe3+ chelation fully rescued cells from ferroptotic cell death
In order to understand how the differential iron transporter expression influences iron content of ARPE-19 cells, we measured Fe2+ and Fe3+ levels by flow cytometry. SI treatment alone for 8 h led to a significant decrease in intracellular Fe2+ levels. Interestingly, Fe3+ levels were already elevated by SI or DMOG treatment alone but displayed the highest levels in DMOG + SI co-treated cells (Fig. 5A–C). Thus, our data suggest that either Fe3+ import is higher or oxidation of Fe2+ to Fe3+ is increased in the SI + DMOG co-treated group due to induced Fenton reaction. To test, if Fe3+ or Fe2+ levels are involved in cell death, we treated ARPE-19 cells with an Fe3+ chelator Deferoxamine Mesylate and an Fe2+ chelator 2’2-Bipyridyl along with DMOG + SI co-treatment. While Deferoxamine Mesylate did not reduce LDH release, i.e. cell death, even at very high concentrations (Fig. 5D), 2’2-Bipyridyl reduced cell death in a concentration-dependent manner and fully rescued cells at concentrations of 500 µM and 1 mM (Fig. 5E).
Discussion
The pathophysiology of AMD is complex and involves many risk factors. The primary factor is advanced age due to its association with decreasing antioxidant defense mechanisms and structural changes in the blood retinal barrier favoring chronic hypoxia in the macular region. To date many studies have used SI to induce ROS production in RPE cells because SI treatment leads to RPE atrophy and secondary photoreceptor degeneration resembling AMD pathophysiology in vivo. Therefore, SI treatment has been widely used as a model for dry AMD in vivo and in vitro [16, 18, 20, 41,42,43,44,45]. However, inducing oxidative stress alone does not fully resemble age-related morphological changes contributing to AMD pathophysiology, particularly chronic hypoxia-associated effects. Therefore, we aimed to develop an in vitro RPE model using ARPE-19 cells to investigate the role of HIFs in oxidative stress-induced RPE degeneration and the cell death pathways involved in RPE atrophy to provide new approaches for future treatment strategies for dry AMD.
To our surprise, SI-induced cell death was substantially increased when HIFs were stabilized by DMOG, suggesting that HIF stabilization aggravates oxidative stress-induced cell death. We found that Fer-1 and Lip-1, two highly potent ferroptosis inhibitors fully rescued ARPE-19 cells co-treated with DMOG and SI. This is in line with two studies in which oxidative stress induced by tert-butyl hydroperoxide or SI resulted in ferroptotic cell death in ARPE-19 cells [43, 46]. We also found higher levels of the oxidized form of the lipid peroxidation sensor BODIPY-C11 to be localized in the perinuclear space of DMOG + SI co-treated cells which is typically found in cells facing lipid peroxidation, the critical step of ferroptosis [47]. In line with our findings, lipid peroxidation in the context of AMD was already reported before ferroptosis was established as a cell death pathway [48]. However, we also found that the RIPK3/necroptosis inhibitor GSK872, completely inhibited cell death, while RIPK1 (by Nec-1s) and MLKL (by NSA) inhibition decreased cell death but were not able to rescue cells as it would be expected if necroptosis was the major cell death pathway. This finding is in contrast to a study where SI was reported to induce necroptosis in ARPE-19 cells and mouse RPE [16]. However, the authors used Nec-1 (not Nec-1s, which is more selective for RIPK1), a RIPK1 inhibitor with ferroptosis-associated off-target effects [49] and inhibition of MLKL, the final step of the necroptosis pathway, was not conducted. On the other hand, the authors reported an involvement of RIPK3, which was shown by e.g. formation of RIPK3 aggregates. A crosstalk between necroptosis and ferroptosis was already reported which might explain rescue of ARPE-19 cells by RIPK3 inhibition although necroptosis is not the major death pathway [50]. Consequently, our results make it most likely that HIF stabilization under oxidative stress conditions aggravates ferroptotic cell death resembling the pathophysiology of dry AMD.
It must be noted that DMOG stabilizes both, HIF-1α and HIF-2α. Previous studies have demonstrated that these two HIF isoforms play differential roles in ferroptosis with partially contradicting results. For instance, HIF-2α was associated with higher ferroptosis susceptibility in colorectal cancer cells, in murine colon tumors [51] and clear cell carcinoma cells [52] by regulation of cellular lipid and iron metabolism. However, HIF-2 signaling was also reported to reduce oxidative stress by inducing the transcription of nucleoside diphosphate-linked moiety X-type motif 1 in clear cell renal cell carcinoma, which promoted tumor growth [53]. HIF-1α, on the other hand, was attributed a protective effect against ferroptosis in several cancer cells by reducing iron and ROS levels [54], promoting lipid storage and regulating lipid metabolism [55,56,57]. In line with previous observations, high expression of the HIF-1 target gene carbonic anhydrase 9 had protective effects against ferroptosis in a model of malignant mesothelioma [58]. Moreover, in ferroptosis-induced brain injury and liver fibrosis models, HIF-1α suppressed ferroptosis [59, 60]. However, in non-small cell lung cancer cells and ES-2 ovarian cancer cells, HIF-1α aggravated ferroptotic cell death. Similarly, a study in a mouse model of diabetic renal tubular injury indicated that ferroptosis was aggravated by activation of the HIF-1α/ heme oxygenase-1 pathway [61]. Moreover, ZIP8 and ZIP14 were reported to be upregulated in a HIF-1α-dependent manner [62], which could have contributed to increased Fe2+ import in our cell model as well. Taken together, HIF signaling influences the extent of ferroptotic cell death but the differential roles of HIF-1α and HIF-2α in ferroptosis regulation turn out very differently depending on the type of disease and tissue. Thus, as a future perspective, targeted manipulation of HIF-1 and/or HIF-2 signaling in AMD-RPE models are needed to reveal novel therapeutic opportunities.
Based on our findings, we propose two crucial steps leading to ferroptosis aggravation with HIF stabilization: First, we found increased SOD activity combined with unaffected GPX1 and GPX4 levels which likely led to higher H2O2 levels because GPXs could not compensate for increased H2O2 production by SODs. In line with our findings, higher SOD activity paired with decreased GPX activity in human erythrocytes was correlated with a significantly higher risk for AMD [63]. Elevated SOD activity paired with unchanged GPX1 activity have also been reported in fibromyalgia patients, a pain syndrome associated with increased lipid peroxidation [64, 65]. Moreover, several studies have demonstrated a peroxidative rather than antioxidative role of SODs under specific circumstances: SOD2 overexpression led to an increase of H2O2 in fibrosarcoma cells [66] and SOD2 displays peroxidase activity in presence of high H2O2 concentrations [67]. Under manganese-deficient conditions, SOD2 can incorporate iron instead of manganese, resulting in an alternative SOD2 isoform with peroxidase activity [68]. In all these cases, cellular energy metabolism was impaired, similar to data obtained from RPE cells from AMD patients [69]. In addition, SOD2 exacerbated ischemia-reperfusion damage in isolated hearts when administered at high doses [70] and elevated SOD1 activity was demonstrated to be responsible for oxidative stress, protein oxidation, lipid peroxidation, presumably leading to mitochondrial dysfunction and accelerated cellular senescence in Down’s syndrome [71,72,73]. It must be noted that under physiological conditions, low SOD levels are sufficient to dismutate most O2−. Thus, increased SOD activity does not necessarily increase H2O2 levels [74]. However, a central pathophysiological characteristic of AMD is the accumulation of lipofuscin, a potent photoinducible ROS generator, which is associated with increased levels of O2−, singlet oxygen, H2O2 and lipid hydroperoxides [75]. In our AMD cell culture model, we used SI, which resembles lipofuscin-induced O2- production. Consequently, elevated SOD activity along with unchanged or even decreased GPX activity could represent a central pathophysiological mechanism leading to photoreceptor damage.
Second, increased abundance of the Fe2+ importers ZIP8 and ZIP14 was described to lead to higher non-transferrin-bound iron import [76, 77]. While the main regulators of transferrin-bound iron import, TFR1 and DMT1 were not differently regulated on protein level, ZIP8 and ZIP14 were upregulated by DMOG + SI co-treatment, suggesting that Fe2+ import was increased. While the transferrin-bound iron import can be negatively regulated by intracellular iron levels [77], which was also observed on DMT1 gene expression level in the present study, ZIP8 and ZIP14 protein levels were reported to be positively regulated by intracellular iron levels in the mouse retina [77] which corroborates our findings. Measurement of Fe2+ and Fe3+ levels revealed that Fe2+ levels were decreased in SI-treated cells presumably due to decreased transferrin-bound iron import. Fe3+ levels were increased by DMOG + SI co-treatment suggesting that Fe2+ to Fe3+ oxidation could be upregulated due to the Fenton reaction where oxidation of Fe2+ leads to the generation of hydroxyl radicals. Besides the above-mentioned iron transporters, a process known as ferritinophagy contributes to the intracellular iron pool as well. Ferritinophagy is an autophagy-related process which releases iron from ferritin. Thus, dysregulation of ferritinophagy can promote ferroptosis. Hypoxia and HIF-1α were reported to inhibit ferritinophagy in macrophages and osteoclasts [78, 79], while HIF-2 signaling increased expression of nuclear receptor coactivator 4, which promotes the degradation of ferritin in autophagosomes, in mouse enterocytes [80, 81]. Interestingly, we did not see differences in FTL or FTH protein levels in DMOG-treated cells, presumably because HIF-1 and -2 effects neutralized each other. In SI and DMOG + SI co-treated cells, FTL was significantly upregulated, which was most likely a result of increased intracellular iron [82]. Still, it was not sufficient to avoid ferroptotic cell death. To test whether non-transferrin-bound Fe2+ import and not transferrin-bound Fe3+ import was responsible for ferroptosis aggravation in DMOG + SI co-treated cells, we chelated Fe2+ with 2’2-Bipyridyl that resulted in full rescue of cells. In contrast, Fe3+ chelation did not influence cell death, which is in contrast to studies where the Fe3+ chelator Deferoxamine was used to inhibit ferroptosis [43, 83]. This suggests that the combination of oxidative stress and hypoxia induces ferroptosis by a hitherto unknown pathway, where SODs and non-transferrin-bound iron import play a pathophysiological role.
Taken together, our study provides a novel link between hypoxia, oxidative stress and iron metabolism in AMD pathophysiology. Our data demonstrate for the first time that HIF stabilization under oxidative stress conditions aggravates the Fenton reaction in RPE cells. Our findings are in line with reports of increased iron levels in the retina, RPE and Bruch’s membrane of AMD patients [84,85,86,87,88,89,90] and studies where iron reduction led to decreased cell death in RPE cells [91,92,93] implying that dry AMD pathophysiology was resembled in our cell culture model. Thus, our model provides a unique opportunity to test different compounds reducing iron overload and ferroptosis in a high throughput approach.
Data availability
The numerous datasets generated in the current study will be made available upon request.
References
Fernandes AR, Zielińska A, Sanchez-Lopez E, dos Santos T, Garcia ML, Silva AM, et al. Exudative versus nonexudative age-related macular degeneration: Physiopathology and treatment options. Int J Mol Sci. 2022;23. https://doi.org/10.3390/ijms23052592.
Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–e116.
Arjamaa O, Nikinmaa M, Salminen A, Kaarniranta K. Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD). Ageing Res Rev. 2009;8:349–58.
Kurihara T, Westenskow PD, Gantner ML, Usui Y, Schultz A, Bravo S, et al. Hypoxia-induced metabolic stress in retinal pigment epithelial cells is sufficient to induce photoreceptor degeneration. eLife. 2016;5. https://doi.org/10.7554/eLife.14319.
Soundara Pandi SP, Ratnayaka JA, Lotery AJ, Teeling JL. Progress in developing rodent models of age-related macular degeneration (AMD). Exp Eye Res. 2021;203. https://doi.org/10.1016/j.exer.2020.108404.
Blasiak J, Petrovski G, Veréb Z, Facskó A, Kaarniranta K. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. Biomed Res Int 2014;2014. https://doi.org/10.1155/2014/768026.
Datta S, Cano M, Ebrahimi K, Wang L, Handa JT. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 2017;60:201–18.
Stahl A. The diagnosis and treatment of age-related macular degeneration. Dtsch Arztebl Int. 2020;117:513–20.
Cabral de Guimaraes TA, Daich Varela M, Georgiou M, Michaelides M. Treatments for dry age-related macular degeneration: Therapeutic avenues, clinical trials and future directions. Br J Ophthalmol. 2021;106:297–304.
Yang M, So KF, Lam WC, Lo ACY. Novel programmed cell death as therapeutic targets in age-related macular degeneration? Int J Mol Sci. 2020;21. https://doi.org/10.3390/ijms21197279.
Tong Y, Wang S. Not all stressors are equal: Mechanism of stressors on RPE cell degeneration. Front Cell Dev Biol 2020;8. https://doi.org/10.3389/fcell.2020.591067.
Zhao T, Guo X, Sun Y. Iron accumulation and lipid peroxidation in the aging retina: Implication of ferroptosis in age-related macular degeneration. Aging Dis. 2021;12:529–51.
Zacks DN, Kocab AJ, Choi JJ, Gregory-Ksander MS, Cano M, Handa JT. Cell death in AMD: The rationale for targeting Fas. J Clin Med. 2022;11.
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25:486–541.
Li J, Cao F, Yin HL, Huang Z, Lin Z, Mao N, et al. Ferroptosis: Past, present and future. Cell Death Dis 2020;11. https://doi.org/10.1038/s41419-020-2298-2.
Hanus J, Anderson C, Sarraf D, Ma J, Wang S. Retinal pigment epithelial cell necroptosis in response to sodium iodate. Cell Death Discov. 2016;2. https://doi.org/10.1038/cddiscovery.2016.54.
Kaczara P, Sarna T, Burke JM. Dynamics of H2O2 availability to ARPE-19 cultures in models of oxidative stress. Free Radic Biol Med. 2010;48:1064–70.
Zhang XY, Ng TK, Brelén ME, Wu D, Wang JX, Chan KP, et al. Continuous exposure to non-lethal doses of sodium iodate induces retinal pigment epithelial cell dysfunction. Sci Rep. 2016;6. https://doi.org/10.1038/srep37279.
Masuda N, Tsujinaka H, Hirai H, Yamashita M, Ueda T, Ogata N. Effects of concentration of amyloid β (Aβ) on viability of cultured retinal pigment epithelial cells. BMC Ophthalmol. 2019;19. https://doi.org/10.1186/s12886-019-1076-3.
Lin YC, Horng LY, Sung HC, Wu RT. Sodium iodate disrupted the mitochondrial-lysosomal axis in cultured retinal pigment epithelial cells. J Ocul Pharm Ther. 2018;34:500–11.
Greijer AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, Meijer GA, et al. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol. 2005;206:291–304.
Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, Jiang BH, et al. Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int. 1997;51:553–5.
Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res. 2006;71:642–51.
Leu T, Schützhold V, Fandrey J, Ferenz KB. When the brain yearns for oxygen. Neurosignals. 2019;27:50–61.
Lange CA, Bainbridge JW. Oxygen sensing in retinal health and disease. Ophthalmologica. 2012;227:115–31.
Barben M, Schori C, Samardzija M, Grimm C. Targeting Hif1a rescues cone degeneration and prevents subretinal neovascularization in a model of chronic hypoxia. Mol Neurodegener. 2018;13. https://doi.org/10.1186/s13024-018-0243-y.
Peters F, Ebner LJA, Atac D, Maggi J, Berger W, den Hollander AI, et al. Regulation of ABCA1 by AMD-associated genetic variants and hypoxia in iPSC-RPE. Int J Mol Sci. 2022;23. https://doi.org/10.3390/ijms23063194.
Yu DY, Cringle SJ. Retinal degeneration and local oxygen metabolism. Exp Eye Res. 2005;80:745–51.
Yu DY, Cringle SJ. Oxygen distribution in the mouse retina. Investig Ophthalmol Vis Sci. 2006;47:1109–12.
Linsenmeier RA, Zhang HF. Retinal oxygen: From animals to humans. Prog Retin Eye Res. 2017;58:115–51.
Hanus J, Anderson C, Wang S. RPE necroptosis in response to oxidative stress and in AMD. Ageing Res Rev. 2015;24:286–98.
Balmer J, Zulliger R, Roberti S, Enzmann V. Retinal cell death caused by sodium iodate involves multiple caspase-dependent and caspase-independent cell-death pathways. Int J Mol Sci. 2015;16:15086–103.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−δδct method. Methods. 2001;25:402–8.
Krysztofiak A, Szymonowicz K, Hlouschek J, Xiang K, Waterkamp C, Larafa S, et al. Metabolism of cancer cells commonly responds to irradiation by a transient early mitochondrial shutdown. iScience. 2021;24. https://doi.org/10.1016/j.isci.2021.103366.
Petrat F, Weisheit D, Lensen M, de Groot H, Sustmann R, Rauen U. Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. Biochem J. 2002;362:137–47.
Santambrogio P, Dusi S, Guaraldo M, Rotundo LI, Broccoli V, Garavaglia B, et al. Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients. Neurobiol Dis. 2015;81:144–53.
Lytton SD, Mester B, Libman J, Shanzer A, Ioav Cabantchik Z. Monitoring of iron(III) removal from biological sources using a fluorescent siderophore. Anal Biochem. 1992;205:326–33.
Lord SJ, Velle KB, Mullins RD, Fritz-Laylin LK. Superplots: Communicating reproducibility and variability in cell biology. J Cell Biol. 2020;219. https://doi.org/10.1083/jcb.202001064.
Naegle K, Gough NR, Yaffe MB. Criteria for biological reproducibility: What does “n” mean? Sci Signal. 2015;8. https://doi.org/10.1126/scisignal.aab1125.
Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M, et al. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci. 2017;3:232–43.
Hsu MY, Hsiao YP, Lin YT, Chen C, Lee CM, Liao WC, et al. Quercetin alleviates the accumulation of superoxide in sodium iodate-induced retinal autophagy by regulating mitochondrial reactive oxygen species homeostasis through enhanced deacetyl-SOD2 via the NRF2-PGC-1α-SIRT1 pathway. Antioxidants (Basel). 2021;10. https://doi.org/10.3390/antiox10071125.
Bhutto IA, Ogura S, Baldeosingh R, McLeod DS, Lutty GA, Edwards MM. An acute injury model for the phenotypic characteristics of geographic atrophy. Invest Ophthalmol Vis Sci. 2018;59:143–51.
Liu B, Wang W, Shah A, Yu M, Liu Y, He L, et al. Sodium iodate induces ferroptosis in human retinal pigment epithelium ARPE-19 cells. Cell Death Dis. 2021;12. https://doi.org/10.1038/s41419-021-03520-2.
Ma H, Yang F, Ding XQ. Inhibition of thyroid hormone signaling protects retinal pigment epithelium and photoreceptors from cell death in a mouse model of age-related macular degeneration. Cell Death Dis. 2020;11. https://doi.org/10.1038/s41419-019-2216-7.
Obata R, Yanagi Y, Tamaki Y, Hozumi K, Mutoh M, Tanaka Y. Retinal degeneration is delayed by tissue factor pathway inhibitor-2 in RCS rats and a sodium-iodate-induced model in rabbits. Eye. 2005;19:464–8.
Totsuka K, Ueta T, Uchida T, Roggia MF, Nakagawa S, Vavvas DG, et al. Oxidative stress induces ferroptotic cell death in retinal pigment epithelial cells. Exp Eye Res. 2019;181:316–24.
Drummen GPC, van Liebergen LCM, Op den Kamp JAF, Post JA. C11-BODIPY581/591, an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology. Free Radic Biol Med. 2002;33:473–90.
Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis. 1999;5:32.
Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator GPX4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16:1180–91.
Zhou Y, Liao J, Mei Z, Liu X, Ge J. Insight into crosstalk between ferroptosis and necroptosis: Novel therapeutics in ischemic stroke. Oxid Med Cell Longev. 2021;2021. https://doi.org/10.1155/2021/9991001.
Singhal R, Mitta SR, Das NK, Kerk SA, Sajjakulnukit P, Solanki S, et al. HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron. J Clin Investig. 2021;131. https://doi.org/10.1172/jci143691.
Zou Y, Palte MJ, Deik AA, Li H, Eaton JK, Wang W, et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun 2019;10. https://doi.org/10.1038/s41467-019-09277-9.
Shi J, Xiong Z, Wang K, Yuan C, Huang Y, Xiao W, et al. HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress. Clin Transl Med. 2021;11. https://doi.org/10.1002/ctm2.592.
Lin Z, Song J, Gao Y, Huang S, Dou R, Zhong P, et al. Hypoxia-induced HIF-1α/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer. Redox Biol 2022;52. https://doi.org/10.1016/j.redox.2022.102312.
Yang M, Chen P, Liu J, Zhu S, Kroemer G, Klionsky DJ, et al. Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci Adv. 2019;5. https://doi.org/10.1126/sciadv.aaw2238.
Bensaad K, Favaro E, Lewis CA, Peck B, Lord S, Collins JM, et al. Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation. Cell Rep. 2014;9:349–65.
Huang D, Li T, Li X, Zhang L, Sun L, He X, et al. HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. Cell Rep. 2014;8:1930–42.
Li Z, Jiang L, Chew SH, Hirayama T, Sekido Y, Toyokuni S. Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia. Redox Biol. 2019;26. https://doi.org/10.1016/j.redox.2019.101297.
Cui Y, Zhang Y, Zhao X, Shao L, Liu G, Sun C, et al. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation. Brain Behav Immun. 2021;93:312–21.
Yuan S, Wei C, Liu G, Zhang L, Li J, Li L, et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway. Cell Prolif. 2022;55. https://doi.org/10.1111/cpr.13158.
Feng X, Wang S, Sun Z, Dong H, Yu H, Huang M, et al. Ferroptosis enhanced diabetic renal tubular injury via HIF-1α/HO-1 pathway in db/db mice. Front Endocrinol. 2021;12. https://doi.org/10.3389/fendo.2021.626390.
Hatano N, Matsubara M, Suzuki H, Muraki Y, Muraki K. HIF-1α dependent upregulation of ZIP8, ZIP14, and TRPA1 modify intracellular Zn2+ accumulation in inflammatory synoviocytes. Int J Mol Sci. 2021;22. https://doi.org/10.3390/ijms22126349.
Plestina-Borjan I, Katusic D, Medvidovic-Grubisic M, Supe-Domic D, Bucan K, Tandara L, et al. Association of age-related macular degeneration with erythrocyte antioxidant enzymes activity and serum total antioxidant status. Oxid Med Cell Longev 2015;2015. https://doi.org/10.1155/2015/804054.
Akbas A, Inanir A, Benli I, Onder Y, Aydogan L. Evaluation of some antioxidant enzyme activities (SOD and GPX) and their polymorphisms (mnSOD2 Ala9Val, GPX1 Pro198Leu) in fibromyalgia. Eur Rev Med Pharm Sci. 2014;18:1199–203.
Akkuş S, Naziroğlu M, Eriş S, Yalman K, Yilmaz N, Yener M. Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochem Funct. 2009;27:181–5.
Rodrı́guez AM, Carrico PM, Mazurkiewicz JE, Meléndez JA. Mitochondrial or cytosolic catalase reverses the mnSOD-dependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H2O2. Free Radic Biol Med. 2000;29:801–13.
Ansenberger-Fricano K, Ganini D, Mao M, Chatterjee S, Dallas S, Mason RP, et al. The peroxidase activity of mitochondrial superoxide dismutase. Free Radic Biol Med. 2013;54:116–24.
Ganini D, Santos JH, Bonini MG, Mason RP. Switch of mitochondrial superoxide dismutase into a prooxidant peroxidase in manganese-deficient cells and mice. Cell Chem Biol. 2018;25:413–25.
Ferrington DA, Ebeling MC, Kapphahn RJ, Terluk MR, Fisher CR, Polanco JR, et al. Altered bioenergetics and enhanced resistance to oxidative stress in human retinal pigment epithelial cells from donors with age-related macular degeneration. Redox Biol. 2017;13:255–65.
Omar BA, McCord JM. The cardioprotective effect of Mn-superoxide dismutase is lost at high doses in the postischemic isolated rabbit heart. Free Radic Biol Med. 1990;9:473–8.
Rodríguez-Sureda V, Vilches Á, Sánchez O, Audí L, Domínguez C. Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21. Oxid Med Cell Longev 2015;2015. https://doi.org/10.1155/2015/509241.
Kedziora J, Bartosz G. Down’s syndrome: A pathology involving the lack of balance of reactive oxygen species. Free Radic Biol Med. 1988;4:317–30.
Elroy-Stein O, Bernstein Y, Groner Y. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: Extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J. 1986;5:615–22.
Offer T, Russo A, Samuni A. The pro-oxidative activity of SOD and nitroxide SOD mimics. FASEB J. 2000;14:1215–23.
Boulton M, Rózanowska M, Rózanowski B. Retinal photodamage. J Photochem Photobio B. 2001;64:144–61.
Jenkitkasemwong S, Wang CY, Coffey R, Zhang W, Chan A, Biel T, et al. SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis. Cell Metab. 2015;22:138–50.
Sterling J, Guttha S, Song Y, Song D, Hadziahmetovic M, Dunaief JL. Iron importers ZIP8 and ZIP14 are expressed in retina and regulated by retinal iron levels. Exp Eye Res. 2017;155:15–23.
Fuhrmann DC, Mondorf A, Beifuß J, Jung M, Brüne B. Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis. Redox Biol 2020;36. https://doi.org/10.1016/j.redox.2020.101670.
Ni S, Yuan Y, Qian Z, Zhong Z, Lv T, Kuang Y, et al. Hypoxia inhibits RANKL-induced ferritinophagy and protects osteoclasts from ferroptosis. Free Radic Biol Med. 2021;169:271–82.
Finberg KE. Blocking (iron) traffic in the gut. Blood. 2022;139:2424–5.
Das NK, Jain C, Sankar A, Schwartz AJ, Santana-Codina N, Solanki S, et al. Modulation of the HIF2α-NCOA4 axis in enterocytes attenuates iron loading in a mouse model of hemochromatosis. Blood. 2022;139:2547–52.
Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99:3505–16.
Sun Y, Zheng Y, Wang C, Liu Y. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis. 2018;9. https://doi.org/10.1038/s41419-018-0794-4.
Hahn P, Milam AH, Dunaief JL. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and bruch’s membrane. Arch Ophthalmol. 2003;121:1099–105.
Biesemeier A, Yoeruek E, Eibl O, Schraermeyer U. Iron accumulation in Bruch’s membrane and melanosomes of donor eyes with age-related macular degeneration. Exp Eye Res. 2015;137:39–49.
Shahandeh A, Bui BV, Finkelstein DI, Nguyen CTO. Effects of excess iron on the retina: Insights from clinical cases and animal models of iron disorders. Front Neurosci. 2021;15. https://doi.org/10.3389/fnins.2021.794809.
Dunaief JL, Richa C, Franks EP, Schultze RL, Aleman TS, Schenck JF, et al. Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology. 2005;112:1062–5.
Chowers I, Wong R, Dentchev T, Farkas RH, Iacovelli J, Gunatilaka TL, et al. The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:2135–40.
Ugarte M, Geraki K, Jeffery G. Aging results in iron accumulations in the non-human primate choroid of the eye without an associated increase in zinc, copper or sulphur. Biometals. 2018;31:1061–73.
Dentchev T, Hahn P, Dunaief JL. Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch Ophthalmol. 2005;123:1745–6.
Song Q, Zhao Y, Yang Y, Han X, Duan J. Astragaloside IV protects against retinal iron overload toxicity through iron regulation and the inhibition of MAPKs and NF-κB activation. Toxicol Appl Pharmacol. 2021;410. https://doi.org/10.1016/j.taap.2020.115361.
Kurz T, Karlsson M, Brunk UT, Nilsson SE. ARPE-19 retinal pigment epithelial cells are highly resistant to oxidative stress and exercise strict control over their lysosomal redox-active iron. Autophagy. 2009;5:494–501.
Lukinova N, Iacovelli J, Dentchev T, Wolkow N, Hunter A, Amado D, et al. Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli. Investig Ophthalmol Vis Sci. 2009;50:1440–7.
Acknowledgements
The work was supported by grant from European Union’s Framework Program for Research and Innovation Horizon 2020 (2014-2020) under Marie Skłodowska-Curie (Grant Agreements No. 860245 (ITN THERADNET) to JM), the Federal Ministry of Education and Research (BMBF, 02NUK061B) to JM, the intramural WIR-grant of the Medical Faculty of the University of Duisburg-Essen to JM and YH, and by the PRO RETINA foundation to prevent blindness, Germany, granted to YH (Pro-Re/KP/Henning.09-2021). We thank B. Delos-Reyes and C. Padberg for technical assistance, the Institute of Medical Psychology for providing access to the FACSCelesta TM Flow Cytometer, V. Matschke for providing the FTH antibody, and Andreas Wagner and Markus Hecker (University of Heidelberg) for helpful discussions. We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
Conceived the study and experimental design: YH, JF. Performed experiments: YH, USB, SL, JM. Analysed data: YH, USB, SL, JM. Wrote the manuscript: YH with significant input from USB, SL, JM, JF. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Professor Boris Zhivotovsky
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Henning, Y., Blind, U.S., Larafa, S. et al. Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction. Cell Death Dis 13, 662 (2022). https://doi.org/10.1038/s41419-022-05121-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-022-05121-z
This article is cited by
-
Protective effect of ghrelin in oxidative stress-induced age-related macular degeneration in vitro and in vivo
Molecular Medicine (2024)
-
Gastrodin prevents myocardial injury in sleep-deprived mice by suppressing ferroptosis through SIRT6
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
-
Exploring retinal degenerative diseases through CRISPR-based screening
Molecular Biology Reports (2024)
-
Minocycline alleviates microglia ferroptosis by inhibiting HO-1 during cerebral ischemia–reperfusion injury
Inflammation Research (2024)
-
The mechanism of ferroptosis and its related diseases
Molecular Biomedicine (2023)